Nov 9, 2024, 16:34
Because of research we can effectively treat ALK-positive lung cancer and longer life expectancy- ALK Positive Inc.
ALK Positive Inc. shared a post on LinkedIn:
“Until 2007, about one in twenty lung cancer patients all had one thing in common but did not know it: an alteration of the ALK gene that we’re all born with.
It’s thanks to research that we not only know about ALK-positive lung cancer but can effectively treat it for a longer life expectancy.
Dr Ross Camidge believes research can help us do even better. ”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43
Nov 12, 2024, 19:34